Structure

InChI Key BNRNXUUZRGQAQC-UHFFFAOYSA-N
Smile CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12
InChI
InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H30N6O4S
Molecular Weight 474.59
AlogP 1.61
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 7.0
Polar Surface Area 113.42
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 33.0

Pharmacology

Primary Target
phosphodiesterase 5A
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Oxidoreductase
- 4500 - - -
Enzyme Phosphodiesterase Phosphodiesterase 1 Phosphodiesterase 1A
- 270-1500 - - -
Enzyme Phosphodiesterase Phosphodiesterase 1 Phosphodiesterase 1B
- 270-1500 - - -
Enzyme Phosphodiesterase Phosphodiesterase 1 Phosphodiesterase 1C
- 270-1500 - - -
Enzyme Phosphodiesterase Phosphodiesterase 10 Phosphodiesterase 10A
- 3100-6800 - - -
Enzyme Phosphodiesterase Phosphodiesterase 11 Phosphodiesterase 11A
- 2300-7800 - - -
Enzyme Phosphodiesterase Phosphodiesterase 2 Phosphodiesterase 2A
- 43000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 3 Phosphodiesterase 3A
- 7000-65000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 3 Phosphodiesterase 3B
- 7000-65000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 4 Phosphodiesterase 4A
- 7800-11000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 4 Phosphodiesterase 4B
- 7800-11000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 4 Phosphodiesterase 4C
- 7800-11000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 4 Phosphodiesterase 4D
- 7800-11000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 5 Phosphodiesterase 5A
9-1000 1-12590 - 2-10 55-100
Enzyme Phosphodiesterase Phosphodiesterase 6 Phosphodiesterase 6A
- 20-74 - 50 -
Enzyme Phosphodiesterase Phosphodiesterase 6 Phosphodiesterase 6B
- 20-74 - 50 -
Enzyme Phosphodiesterase Phosphodiesterase 6 Phosphodiesterase 6C
- 20-74 - 25 -
Enzyme Phosphodiesterase Phosphodiesterase 6 Phosphodiesterase 6D
- 20-74 - 50 -
Enzyme Phosphodiesterase Phosphodiesterase 6 Phosphodiesterase 6G
- 20-74 - 50 -
Enzyme Phosphodiesterase Phosphodiesterase 6 Phosphodiesterase 6H
- 20-74 - 50 -
Enzyme Phosphodiesterase Phosphodiesterase 7 Phosphodiesterase 7A
- 4690-22000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 8 Phosphodiesterase 8A
- 100000 - - -
Enzyme Phosphodiesterase Phosphodiesterase 9 Phosphodiesterase 9A
- 3400-5600 - - -
Enzyme
9-1000 1-12590 - 2-10 55-100
Ion channel Voltage-gated ion channel Potassium channels Voltage-gated potassium channel
- 3300-100000 - - -
Ion channel Voltage-gated ion channel Voltage-gated calcium channel
- 100000 - - -
Membrane receptor Family A G protein-coupled receptor Small molecule receptor (family A GPCR) Nucleotide-like receptor (family A GPCR) Adenosine receptor
- - - 200 -
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 22
Transporter Electrochemical transporter
- - - - 22
Transporter Primary active transporter ATP-binding cassette ABCB subfamily
- 16430 - - -
Transporter Primary active transporter ATP-binding cassette ABCC subfamily
- - - 1200 85

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Erectile Dysfunction 4 D007172 ClinicalTrials
Erectile Dysfunction 4 D007172 ClinicalTrials
Hypertension 3 D006973 ClinicalTrials
Scleroderma, Systemic 3 D012595 ClinicalTrials
Glaucoma 3 D005901 ClinicalTrials
Idiopathic Pulmonary Fibrosis 3 D054990 ClinicalTrials
Heart Failure 3 D006333 ClinicalTrials
Diabetes Mellitus 3 D003920 ClinicalTrials
Hypertension, Pulmonary 3 D006976 ClinicalTrials
Persistent Fetal Circulation Syndrome 3 D010547 ClinicalTrials
Coronary Vasospasm 3 D003329 ClinicalTrials
Peripheral Arterial Disease 3 D058729 ClinicalTrials
Heart Failure 3 D006333 ClinicalTrials
Hypertension, Pulmonary 3 D006976 ClinicalTrials
Eisenmenger Complex 3 D004541 ClinicalTrials
Lung Diseases 3 D008171 ClinicalTrials
Arterial Occlusive Diseases 3 D001157 ClinicalTrials
Bronchopulmonary Dysplasia 2 D001997 ClinicalTrials
Sexual Dysfunction, Physiological 2 D012735 ClinicalTrials
Cystic Fibrosis 2 D003550 ClinicalTrials
Prostatic Hyperplasia 2 D011470 ClinicalTrials
Fetal Growth Retardation 2 D005317 ClinicalTrials
Premature Birth 2 D047928 ClinicalTrials
Parkinson Disease 2 D010300 ClinicalTrials
Muscular Dystrophy, Duchenne 2 D020388 ClinicalTrials
Infertility 2 D007246 ClinicalTrials
Raynaud Disease 2 D011928 ClinicalTrials
Pre-Eclampsia 2 D011225 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Skin Ulcer 2 D012883 ClinicalTrials
Muscular Dystrophy, Duchenne 2 D020388 ClinicalTrials
Cerebral Small Vessel Diseases 2 D059345 ClinicalTrials
Priapism 2 D011317 ClinicalTrials
Brain Injuries 2 D001930 ClinicalTrials
Pregnancy 2 D011247 ClinicalTrials
Scleroderma, Localized 2 D012594 ClinicalTrials
Hypoplastic Left Heart Syndrome 2 D018636 ClinicalTrials
Severe Acute Respiratory Syndrome 1 D045169 ClinicalTrials
Coronary Disease 1 D003327 ClinicalTrials
Infertility, Female 1 D007247 ClinicalTrials
Liver Cirrhosis 1 D008103 ClinicalTrials
Acute Kidney Injury 1 D058186 ClinicalTrials
Mycobacterium Infections 1 D009164 ClinicalTrials
Urinary Incontinence 1 D014549 ClinicalTrials
Heart Diseases 1 D006331 ClinicalTrials
Myelodysplastic Syndromes 1 D009190 ClinicalTrials
Anemia, Sickle Cell 1 D000755 ClinicalTrials
Brain Diseases 1 D001927 ClinicalTrials
Ischemic Stroke 1 D000083242 ClinicalTrials
Lymphangioma 1 D008202 ClinicalTrials
Pulmonary Embolism 1 D011655 ClinicalTrials
Hepatitis C 1 D006526 ClinicalTrials
Migraine with Aura 0 D020325 ClinicalTrials
Pulmonary Edema 0 D011654 ClinicalTrials
Foramen Ovale, Patent 0 D054092 ClinicalTrials
Skin Diseases 0 D012871 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 139755-83-2
ChEBI 9139
ChEMBL CHEMBL192
DrugBank DB00203
DrugCentral 2441
EPA CompTox DTXSID6023579
FDA SRS 3M7OB98Y7H
Human Metabolome Database HMDB0005039
Guide to Pharmacology 4743
KEGG C07259
PDB VIA
PharmGKB PA451346
PubChem 135398744
SureChEMBL SCHEMBL1895
ZINC ZINC000019796168